SYNDACCESS Trademark

Trademark Overview


On Tuesday, February 27, 2024, a trademark application was filed for SYNDACCESS with the United States Patent and Trademark Office. The USPTO has given the SYNDACCESS trademark a serial number of 98423868. The federal status of this trademark filing is SU - NON-FINAL ACTION - MAILED as of Thursday, April 2, 2026. This trademark is owned by Syndax Pharmaceuticals, Inc.. The SYNDACCESS trademark is filed in the Insurance & Financial Services, Computer & Software Services & Scientific Services, Medical & Beauty Services & Agricultural Services, Personal, and Legal & Social Services categories with the following description:

Providing information in the field of cancer treatment; providing medical information about cancer treatment and access to medical care

Providing information about medical and scientific research in the field of cancer treatment

Providing personal support services for patients in the field of cancer treatment, namely, emotional counseling and emotional support

Providing financial assistance programs to qualified patients who have a demonstrated financial need for health services and cancer treatment; providing eligible patients financial support, namely, financial assistance for reducing costs for cancer treatment
syndaccess

General Information


Serial Number98423868
Word MarkSYNDACCESS
Filing DateTuesday, February 27, 2024
Status807 - SU - NON-FINAL ACTION - MAILED
Status DateThursday, April 2, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 14, 2025

Trademark Statements


Goods and ServicesProviding information in the field of cancer treatment; providing medical information about cancer treatment and access to medical care
Goods and ServicesProviding information about medical and scientific research in the field of cancer treatment
Goods and ServicesProviding personal support services for patients in the field of cancer treatment, namely, emotional counseling and emotional support
Pseudo MarkSYND ACCESS
Goods and ServicesProviding financial assistance programs to qualified patients who have a demonstrated financial need for health services and cancer treatment; providing eligible patients financial support, namely, financial assistance for reducing costs for cancer treatment

Classification Information


International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateTuesday, October 22, 2024
Primary Code036
First Use Anywhere DateThursday, October 31, 2024
First Use In Commerce DateThursday, October 31, 2024

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, October 22, 2024
Primary Code042
First Use Anywhere DateThursday, October 31, 2024
First Use In Commerce DateThursday, October 31, 2024

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, October 22, 2024
Primary Code044
First Use Anywhere DateThursday, October 31, 2024
First Use In Commerce DateThursday, October 31, 2024

International Class045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, October 22, 2024
Primary Code045
First Use Anywhere DateThursday, October 31, 2024
First Use In Commerce DateThursday, October 31, 2024

Trademark Owner History


Party NameSyndax Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWaltham, MA 02451
US

Party NameSyndax Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWaltham, MA 02451
US

Trademark Events


Event DateEvent Description
Tuesday, February 27, 2024NEW APPLICATION ENTERED
Monday, July 8, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, September 16, 2024ASSIGNED TO EXAMINER
Wednesday, September 18, 2024NON-FINAL ACTION WRITTEN
Wednesday, September 18, 2024NON-FINAL ACTION E-MAILED
Wednesday, September 18, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, October 22, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, October 22, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 22, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, November 14, 2024EXAMINERS AMENDMENT -WRITTEN
Thursday, November 14, 2024EXAMINERS AMENDMENT E-MAILED
Thursday, November 14, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, November 14, 2024EXAMINER'S AMENDMENT ENTERED
Monday, December 16, 2024EXAMINERS AMENDMENT -WRITTEN
Monday, December 16, 2024EXAMINERS AMENDMENT E-MAILED
Monday, December 16, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, December 16, 2024EXAMINER'S AMENDMENT ENTERED
Monday, December 16, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 8, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 14, 2025PUBLISHED FOR OPPOSITION
Tuesday, January 14, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 11, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, May 21, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Wednesday, May 21, 2025WITHDRAWAL OF ATTORNEY GRANTED
Monday, May 19, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, May 19, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, May 19, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, September 10, 2025TEAS STATEMENT OF USE RECEIVED
Wednesday, March 18, 2026CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, September 10, 2025USE AMENDMENT FILED
Thursday, March 19, 2026STATEMENT OF USE PROCESSING COMPLETE
Thursday, April 2, 2026SU - NON-FINAL ACTION - WRITTEN
Thursday, April 2, 2026NON-FINAL ACTION E-MAILED
Thursday, April 2, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED